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Abstract
Background: Noroviruses are the leading cause of viral gastroenteritis. Because a suitable in vitro
culture system for the human virus has yet to be developed, many basic details of the infection
process are unknown. Murine norovirus (MNV) serves as a model system for the study of
norovirus infection. Recently it was shown that infection of RAW 264.7 cells involved a novel
apoptotic pathway involving survivin.
Results: Using a different set of approaches, the up-regulation of caspases, DNA condensation/
fragmentation, and membrane blebbing, all of which are markers of apoptosis, were confirmed. Live
cell imaging and activity-based protein profiling showed that activation of caspase-like proteases
occurred within two hours of infection, followed by morphological changes to the cells. MNV
infection in the presence of caspase inhibitors proceeded via a distinct pathway of rapid cellular
necrosis and reduced viral production. Affinity purification of activity-based protein profiling targets
and identification by peptide mass fingerprinting showed that the cysteine protease cathepsin B was
activated early in infection, establishing this protein as an upstream activator of the intrinsic
apoptotic pathway.
Conclusion: This work adds cathepsin B to the noncanonical programmed cell death induced by
MNV, and provides data suggesting that the virus may induce apoptosis to expand the window of
time for viral replication. This work also highlights the significant power of activity-based protein
profiling in the study of viral pathogenesis.
Background
Noroviruses are the leading cause of non-bacterial gastro-
enteritis and cause roughly 23 million cases of foodborne
illness annually in the United States alone (CDC, 1999).
The virus infects people of all ages and is highly conta-
gious amongst those susceptible to infection. The illness is
best known for its fast-spreading outbreaks on cruise
ships, college campuses, military bases, nursing homes,
restaurants, and other semi-closed communities. While
the majority of those infected with the virus recover in one
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to three days with no long-term sequelae, roughly 50,000
cases result in hospitalization annually in the U.S. with
~1% of those becoming fatal.
Noroviruses are a group of forty genetically heterogeneous
viruses that belong to the Caliciviridae family. They are
small RNA viruses with positive-sense, single-stranded
genomes of ~7.7 kb. The particles are non-enveloped with
T = 3 icosahedral symmetry, and are ~30 nm in diameter
[1]. Noroviruses are the only group of animal viruses
known to date whose capsid consists of a single protein
form [2]. Attempts to grow human norovirus in cell cul-
ture have been largely unsuccessful [3], leaving many
details of the replication and life-cycle unclear. Recently a
murine norovirus strain (MNV-1) was identified [4] and
has now become a model to study norovirus biology.
MNV-1 has a tropism for dendritic cells and macrophages
and grows to high titers in primary cells and in the cul-
tured macrophage cell line RAW264.7 [5]. Based on the
murine system, advances in elucidating cellular response
to norovirus infection are being reported [6].
During infection, viruses commandeer cellular compo-
nents such as trafficking proteins, membranes, enzymes,
and organelles. Cells attempt to prevent this using a set of
innate systems to combat viruses including establishing
an antiviral state through interferon α/β signaling, RNAi,
and apoptosis. Most viruses encode innate immune eva-
sion strategies or even use cellular defense mechanisms to
their own advantage. Programmed cell death (PCD) or
apoptosis is one of the common pathways activated upon
viral infection. Apoptosis is defined by a set of molecular
characteristics including: chromatin condensation result-
ing from DNA fragmentation [7], cell shrinkage [8], mem-
brane blebbing [9], phosphatidylserine exposure [10],
and caspase activation [11]. While the signature markers
of apoptosis are well characterized, intermediate forms of
PCD have been described, but are not as fully understood.
As a group, they lack one or more of the characteristics
listed above [12]. Necrosis, or basic cell death, occurs
without an orchestrated pattern when the cellular state is
perturbed beyond rebound or physical damage occurs.
Necrosis usually results in an inflammatory immune
response due to leakage of cytoplasmic material.
The carefully controlled genetic and biochemical process
of apoptosis is part of the cellular arsenal for fighting viral
infection. PCD limits the function of cellular machinery
involved in basic metabolic pathways and the time avail-
able for viral replication. Many viruses have evolved anti-
apoptotic strategies to circumvent this mechanism to limit
replication [13-16]. However, some viruses actually take
advantage of PCD and the mechanisms involved. For
example, PCD can provide an avenue for intercellular
transfer of virus in membrane bound bodies, allowing
undetected spread to neighboring cells. Over a dozen
viruses have been documented to induce apoptosis during
infection, each with its own mechanism for activation,
and there are even more viruses that are known to inhibit
apoptosis [12]. The mechanisms for inhibiting apoptosis
target a handful of proteins, including caspases, Bcl-2,
TNF (tumor necrosis factor), NFκB, PKR (dsRNA-depend-
ent protein kinase), p53, and the oxidative stress pathway.
Both NFκB and PKR stimulate interferons (IFNs), which
are critical to the host's defense against viral infection.
Most of the mechanisms that inhibit apoptosis through
Bcl-2, TNF, p53 and NFκB ultimately lead to the preven-
tion of caspase activation; these proteins indirectly acti-
vate the initiator caspases 8 and 9, and later, caspase-3.
Activation leads to DNA fragmentation and apoptosis,
where as blocking the initiator caspases can prevent apop-
tosis.
Interactions between virus and PCD signaling pathways
are currently areas of high interest [14,17,18]. Viral-
induced apoptosis has been demonstrated for a number
of viruses including HIV [19], adenovirus [20], hepatitis C
virus [21], herpes simplex virus [22], human papillomavi-
rus [23], and influenza virus [24]. Apoptosis, as a feature
of calicivirus infection, has recently been characterized by
the increase in caspase-3 activity [10,25-27]. It has also
been proposed that caspase-3 cleaves the norovirus poly-
protein, suggesting that apoptosis might be required for
viral replication [28]. More recently it was demonstrated
that MNV infection induced apoptosis in cultured macro-
phages [29].
This study investigated cellular changes that occur in MNV
infected cells by following the infection of murine macro-
phage cells (RAW 264.7). Analysis of infected cells con-
firmed the up-regulation of caspases, DNA condensation/
fragmentation and membrane blebbing. Activity-based
protein profiling (ABPP) showed that activation of
cysteine proteases occurred within two hours of infection,
rapidly followed by morphological changes to the cells.
The addition of caspase inhibitors during infection led to
rapid cellular necrosis and reduced viral titer. This study
also found cathepsin B to be activated early in infection.
Recent studies by Bok et al [29] found the MNV-cell inter-
action to be novel with respect to PCD in that the protein
survivin is involved. Our results are consistent with their
conclusions that the intrinsic apoptotic pathway becomes
activated in RAW264.7 cells following infection by MNV
and that cathepsin B acts upstream of cytochrome C
release from mitochondria in this process. This is the first
report of cathepsin B involvement in norovirus or viral
infection in general.Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
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Results
Caspase activation in MNV infected RAW264.7 cells
Recently it was shown that MNV-1 infection of RAW264.7
cells induced apoptotic changes. To establish the initial
events during infection that lead to survivin down-regula-
tion and PCD, we investigated caspase activation early in
the infection process. Cell permeable activity-based
probes linked to a fluorescent dye molecule were selected
so that caspase activation could be assessed using live-cell
imaging. We reasoned that this approach would be suffi-
ciently sensitive to detect activation at early time points
and would allow the progress of individual cells to be fol-
lowed, thus avoiding population effects inherent in assays
that require cell lysis.
Total caspase activity was monitored using the FLICA
probe SR-VAD-fmk, (a polycaspase probe reported to rec-
ognize all active capsases) at 2, 4, 8, and 12 hours post
infection (hpi). Fluorescence microscopy showed a clear
increase in caspase activity at 2 hpi compared with mock-
infected control cells (Figure 1). Infected cells were con-
sistently labeled between 2 to 10 hpi with nearly all cells
showing signs of positive labeling. At 12 hpi, intensely
stained cells were observed and a small number had lifted
from the culture plate. A few positively labeled cells were
visible on the control plates, but the number of labeled
cells never exceeded more than a small percent of the
total. The positive signal at 2 hpi was unexpected based on
previous immunoblots that assessed caspase 3 and 9
cleavage [29] and canonical timing of apoptosis. A differ-
ence in these experiments was that here a caspase probe
with broad specificity was used instead of the more selec-
tive probes that target specific members of the caspase
family. MNV, like other RNA viruses, replicates on intrac-
ellular membranes and has been reported to cause a
number of morphological changes to cells as membrane
reorganization [5] and PCD progress [29]. Bright field
images of cells 12 hpi in the FLICA experiment showed
characteristic vesiculation and changes in shape (Figure 2)
as previously described [5]. At this point in the infection
cycle, infected cells were easily distinguished based on
morphology from controls.
Caspase activation follows a defined progression using
intrinsic (mitochondrial) or extrinsic pathways involving
initiator caspases 9 and 8, respectively. The two pathways
merge at the effector capsase 3. To establish which cas-
pase(s) were becoming activated, probes specific for cas-
pases 2, 3/7, 8, and 9 were tested. In this experiment, cell
lysates were analyzed using a fluorescent plate reader to
obtain quantitative results. Infected cells reacted strongly
with the broad spectrum activity probe after only 2 hours
(Figure 3). By 13 hpi the signal from the poly probe was
beginning to decrease while caspase-3/7 was being acti-
vated. The time course of caspase 3/7 activation is consist-
ent with the data reported by Bok et al [29]. Of note, the
previous study analyzed catalytic turnover of a substrate,
whereas the experiments reported here measure the
number of active enzymes present. Based on the activity
curves (Figure 3), the signal from the poly caspase probe
appears to be greater than the sum of the higher specificity
probes prior to 13 hpi.
Caspase activation during MNV-1 infection Figure 1
Caspase activation during MNV-1 infection. Mock-infected (top) and infected (bottom) RAW246.7 cells were incubated 
with a poly caspase specific activity-based probe 2, 4, 8, and 12 hours post infection (left to right). The poly-caspase probe is 
membrane permeable and linked to a sulforhodamine dye.Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
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The induction of PCD in RAW264.7 cells by MNV is rep-
lication dependent, as inactivated virus failed to generate
a response upon cell entry [29]. The mechanism behind
this effect was not determined, however, failed caspase
activation is a possible explanation. For example, caspase
3 is activated by initiator caspases 2, 8, and 9, and by
blocking the initiator, caspase 3 is not activated. Survivin,
an inhibitor of apoptosis (IAP) works by preventing acti-
vation of caspase 9. The caspase probes used in this study
detect the number of active proteins in a cell, but are also
caspase inhibitors. By forming a covalent bond with a cat-
alytic residue side-chain the enzyme is irreversibly inhib-
ited. Because of this, probes were added to the cells,
allowed to react, and after washing were then visualized or
harvested so that they are only reporting on cellular state
at the time of addition.
RAW264.7 cell morphology changes during MNV-1 infection Figure 2
RAW264.7 cell morphology changes during MNV-1 infection. Brightfield cell images of mock-infected (A) and infected 
(B) cells 12 hpi. The cells in panel B have changed in overall shape and are vesiculated.
Caspase activation after MNV-1 infection based on labeling of active proteases in live cells Figure 3
Caspase activation after MNV-1 infection based on labeling of active proteases in live cells. Individual classes of 
caspases were assayed for activity by labeling with membrane permeable covalent activity-based probes coupled to a fluores-
cent dye (n = 3). Activation is reported in relative fluorescence units.Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
Page 5 of 11
(page number not for citation purposes)
Caspase inhibitors accelerate cell death
The rapid activation of caspases and changes in cell mor-
phology described above led us to test whether MNV rep-
lication was dependent on PCD. RAW 264.7 cells were
infected with MNV in the presence of the polycaspase
probe, Boc-D-fmk. The cellular response to infection was
very different in the presence of inhibitor and morpholog-
ical differences were clearly visible 12 hpi. This was not
due to the inhibitor alone, as uninfected cells treated with
Boc-D-fmk remained viable and morphologically indis-
tinct from control cells. Blebbing, swelling, and cytoplas-
mic leaking were evident in cells infected in the presence
of the caspase inhibitor (Figure 4). In the absence of cas-
pase inhibitors, smaller blebs and vesicles were visible at
12 hpi, after which the cells began to shrink and break
apart into apoptotic-like bodies. The presence of activated
macrophages, cells with elongated appendages, which
were common during normal infection (Figure 4 top right
panel and Figure 2B) were less frequent, possibly due to
cells lifting from the plate earlier during the infectious
cycle. Based on the microscopy, the presence of caspase
inhibitors altered the infection process, leading to cell
death that was better described as necrosis than apoptosis.
Cells infected in the presence of the caspase inhibitor died
more rapidly and fewer cells remained attached to the cul-
ture wells at 18 and 24 hpi. To confirm this, plasma mem-
brane integrity was assessed over the course of infection
with trypan blue staining. At 18 hpi less than 20% of the
cells with inhibitor were viable, whereas greater than 80%
where viable in the population that followed the normal
infection process (Figure 5A). This confirmed that cells
infected in the presence and absence of caspase inhibitor
had dramatically different responses.
Apoptosis vs necrosis
The steps and signs of PCD are usually straightforward to
document. Necrosis, on the other hand, is broadly
described by the lack of these features. To get a better
understanding of the different processes that were occur-
ring in the caspase inhibited and non-inhibited infected
RAW264.7 cells, two additional stains were used. Hoechst
staining is commonly used to detect chromatin condensa-
tion due to fragmentation during apoptosis because the
nucleus stains an intense blue, whereas normal nuclear
DNA shows a diffuse pattern of staining. PI can differenti-
ate between live, dead, and apoptotic cells, as apoptotic
cells will fluoresce an intense red, necrotic cell are a dif-
fuse red, and healthy cells will remain unstained. By using
MNV-1 infection with and without caspase inhibitors Figure 4
MNV-1 infection with and without caspase inhibitors. Cell morphology 18 hpi, contol (top row) and caspase-inhibited 
(bottom row) RAW 246.7 cells. Non-infected cells (left) were morphologically unaffected by the presence of the caspase inhib-
itor, Boc-D(MeO)-fmk. Cells infected in the presence of the caspase inhibitor (bottom right) were swollen and bulged, 
whereas those infected without the inhibitor shrank and broke apart.Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
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these two stains in combination it is possible to differen-
tiate between apoptotic and non-apoptotic cell death
[30,31].
After infection, RAW 264.7 cells showed a steady increase
in Hoechst staining over 24 hours, consistent with PCD
(Figure 5B). Cells infected in the presence of the caspase
inhibitor displayed no significant DNA condensation.
These data indicate that DNA fragmentation, resulting in
chromatin condensation, is minimal in cells infected in
the presence of the caspase inhibitor, but extensive in cells
infected without the inhibitor. Parallel cultures stained
with PI showed signs of membrane permeability for both
cell populations; however, cells infected in the presence of
the inhibitor had a more drastic shift to membrane per-
meability than those infected without the inhibitor. By 24
hpi over 75% of the cells undergoing caspase-independ-
ent cell death had permeable membranes. The results
from both Hoechst and PI staining are consistent with a
shift from PCD to necrosis when caspase inhibitors are
present at the time of infection. While this shift might be
predicted, the rapid cell death that ensued was not fore-
seen. As described above, MNV uses a novel mechanism
for inducing PCD that involves down regulation of sur-
vivin. This suggests that PCD of the host cell is somehow
advantageous for viral replication. Virus titers in cell
media collected 24 hpi from cells infected in the presence
or absence of polycaspase inhibitor revealed a reduction
in titer from 7.5 × 106 to 5.1 × 105 pfu/mL, demonstrating
that when PCD pathways were activated, virus replicated
to higher yields.
Cathespin B is activated by viral infection
The chemical tags used in this study to inhibit/tag cas-
pases and fluorometric caspase substrates are widely used
to study apoptosis. Our use of specific and nonspecific
probes raised the question of which protein was responsi-
ble for the strong polycaspase signal observed (Figure 3)
because intrinsic apoptotic pathways involve caspase 9
and then 3, the latter of which came up at the later time
point. The early activation after infection (Figure 1) was
also of interest, because the time course of PCD is usually
slower. These two points, along with the recent report that
MNV uses a novel PCD pathway involving surviving [29]
suggest that an unexpected enzyme could be responsible
for our observed activity. To test this, biotin-X-DEVD-FMK
was used so that labeled proteins could be retrieved using
an affinity column. Infected cells were incubated with the
activity probe and then the total cell lysate was passed
over streptavidin-coated beads. The beads were washed
three times with PBS followed by three high ionic strength
washes (500 mM NaCl) to remove nonspecific binders.
Streptavidin beads were then transferred to 50 mM Tris-
HCl pH 8.0 and incubated overnight with trypsin. Pep-
tides released from the bead bound proteins were directly
analyzed using LC-MS/MS. Cathepsin B and a low level
keratin signal were identified by MASCOT and Phenyx
searches of the mouse and non redundant (nr) databases
(Figure 6). Caspases were not identified in these experi-
ments which could be a reflection of the number of pro-
teins per cell, or the state of activation at the time point
tested. Cathepsin B is a lysosomal protease and member
of a family of 12 cysteine proteases [32,33]. Interestingly,
cathepsin B has been shown to induce apoptosis both
Poly-caspase inhibitor alters the pathway of MNV-1 infection Figure 5
Poly-caspase inhibitor alters the pathway of MNV-1 
infection. RAW 264.7 cells were infected with MNV-1 in 
the presence of the poly-caspase inhibitor, Boc-D-FMK 
(black bars), and without the inhibitor (striped bars). Trypan 
blue staining shows that cell viability decreases much more in 
the presence of inhibitor (A). Only cells infected in the 
absence of the caspase inhibitor show an increase in chroma-
tin condensation as monitored with Hoechst stain (B). Cells 
infected in the presence of inhibitor lose membrane integrity 
more rapidly as monitored by propidium iodide (PI) staining 
(C). (n = 3 for all panels).Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
Page 7 of 11
(page number not for citation purposes)
dependent and independent of caspase activation [32,34-
36]. It can thus function as both an initiator and execu-
tioner protease that acts upstream of cytochrome C release
from mitochondria. Lastly, this protein has been shown to
play multiple roles during viral infection such as PCD sig-
naling with human papilloma virus [37] and uncoating of
adeno-associated viruses 2 and 8 [38] and is induced by
grass carp hemorrhage [39], and influenza A viruses
[20,24,40].
Discussion
The connection between infection and apoptosis is well
described for a number of viruses [19-27]. With respect to
viruses in the Caliciviridae, feline calicivirus activates cas-
pase 3 [27] and caspase 3 cleaves the MNV polyprotein
during viral replication [25]. MNV infection also induces
apoptosis, however, the process appears to be mechanisti-
cally distinct. Previously it was shown that MNV infection
led to activation of the intrinsic PCD pathway with cyto-
chrome C release, caspase 3 and 9 activation and DNA
fragmentation [10]. The data presented in this study con-
firms these results using different methods and extends
them to show that activation of caspase-like proteins
occurs within two hpi, broad specificity caspase inhibitors
accelerate cell death, and cathepsin B, an alternative pro-
tease in PCD identified by activity based screening was
activated by infection.
Morphological changes observed in RAW264.7 cells upon
MNV infection were consistent with those previously
reported. Cell morphology, PI, and Hoechst staining
showed that cells infected in the presence of a polycaspase
inhibitor, Boc-D(OMe)-FMK, follow a distinctly different
mechanism of cell death than cells infected in the absence
of the inhibitor (Figure 5). In the absence of the caspase
inhibitor, a high percentage of infected cells have con-
densed chromatin, and greater than 80 percent have intact
membranes, which is consistent with the morphological
changes associated with apoptosis. In the presence of the
caspase inhibitor, infected cells show morphological signs
of necrosis; very few cells have condensed and the major-
ity has compromised plasma membrane integrity. These
findings provide evidence that RAW 264.7 cells infected
with MNV naturally undergo caspase-mediated apoptosis,
and that caspase inhibitors alter the infection process
leading to a cell death more closely resembling necrosis.
Caspase activation occurs downstream of the mitochon-
drial release of cytochrome c, and does not occur until 8
hpi during FCV infection [10]. Live cell imaging with a
membrane permeable activity probe indicated activation
occurred at a much earlier time point in MNV infected
cells. Specifically, the polycaspase FLICA probe clearly
showed positive labeling 2 hours after infection (Figure
1). This suggests that either caspases become activated
Cathepsin is activated early by MNV-1 infection Figure 6
Cathepsin is activated early by MNV-1 infection. Fragmentation of tryptic peptides in an ion trap mass spectrometer 
was used to identify proteins labeled by a poly-caspase probe. This spectrum shows one of two tryptic peptides identified from 
Cathepsin. Amino acid sequence is shown in reverse order (C to N terminus) to match the Y ion series highlighted by the ver-
tical bars. Ten B ions are also present but not marked. The match was highly significant in Mascot (p = 4.7 × 10-10) and Phenyx 
(p = 2.0 × 10-57) protein identification searches.Virology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
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much earlier during MNV infection of RAW264.7 cells, or
that there is some off target labeling by the probe. The
data presented in figure 3, shows that the polycaspase
FLICA signal is greater than the sum of the specific probes.
The extra signal in this channel could potentially be con-
tributed to caspases that were not tested (1, 4, 6, 10, and
13), however, based on the previous FCV and MNV results
this seems unlikely. We believe that the extra signal
resulted from off-target labeling. This is strongly sup-
ported by the positive identification of cathepsin B by
affinity purification of proteins labeled during infection.
Other groups have suggested that caspase inhibitors are
not highly specific and can target other proteases such as
cathepsins [41-44]. While off-target labeling is a signifi-
cant limitation for traditional uses of such molecules, it is
an advantageous property when combined with affinity
purification and peptide mass finger printing to identify
other active proteases that may play a role in the infection.
Regardless of whether the labeling is on or off-target, the
enzyme must be catalytically active for covalent modifica-
tion to occur. Figure 3 also shows that the more specific
caspase probes are not subject to the same cross reactivity
and activation of caspase 3; this follows closely with the
recently reported data for MNV [29].
The response of murine RAW264.7 cells to MNV infection
clearly involves PCD. It is also apparent that a noncanon-
ical activation pathway for PCD using survivin and cathe-
psin B is involved. This program is initiated within hours
of infection, leading to eventual cell death 24-36 hpi. In
the presence of a pan-caspase inhibitor, cell death is accel-
erated and has the hallmarks of necrosis. A substantial
reduction in the production of infectious virions occurs in
this case - 1-1.5 logs. Numerous viruses take advantage of
the biochemical events of PCD to process polyproteins,
evade immune cell detection, and aid in egress. In the case
of MNV, more virus is produced when PCD is allowed to
progress. While FCV takes advantage of caspase 3 to proc-
ess the polyprotein [25], it is not known if a similar mech-
anism is used by MNV. An explanation that is consistent
with the available data is that MNV has adopted a strategy
in which PCD is allowed to proceed, providing the virus a
larger window of time for replication in comparison to the
rapid necrosis that occurs in the absence of PCD. It is pos-
sible that these results are specific to MNV infection of
RAW 264.7 cells, or could be the result of complex inter-
actions between signaling pathways that are at odds if
MNV infection and caspase inhibition are concurrent.
This hypothesis can be tested and in the process should
shed more light on the noncanonical PCD pathways acti-
vated by MNV and the biological significance of this. Fur-
thermore, this work highlights the significant power of
activity-based protein profiling in the study of viral patho-
genesis.
Materials and methods
Cell Culture
RAW264.7 cells were cultured in Dulbecco's Modified
Eagle's Medium (DMEM) supplemented with 10% pre-
mium-select FBS, 10 mM HEPES, 2 mM L-glutamine, and
25,000 units each of penicillin and streptomycin (com-
plete DMEM). Cells were grown at 37°C with 5% CO2.
Passage number for the cells was kept consistent through-
out the experiments by returning to frozen ATCC stocks as
needed.
Qualitative Caspase Activity
Caspase activity was qualitatively monitored in infected
and mock-infected cells during the first 12 hours of infec-
tion using a fluorescent SR-VAD-fmk poly caspase probe.
Live cell labeling was done according to the FLICA manual
(Immunochemistry Technology, Inc.) with slight modifi-
cations. RAW 264.7 Cells were seeded in 1.0 mL of
cDMEM at a density of 1 × 106 cells per well in 12-well
plates and allowed to grow at 37°C for one day then
infected at an MOI of 3. Every two hours from 0 to 12
h.p.i. one infected and one mock-infected well were
labeled with the FLICA, while one infected and one non-
infected well were left unlabeled. The 0 (zero) time point
was exposed to virus for 5 minutes prior to labeling. At
each time point the media was aspirated and replaced
with either 500 μL of cDMEM containing 1× FLICA
(labeled) or 500 μL of cDMEM (unlabeled). Cells were
incubated in the dark at 37°C for one hour; twice, the
plates were gently tilted to distribute the probe. Cells were
washed three times with 1.0 mL cDMEM for 5 minutes
and 500 μL of fresh cDMEM were added to the cells before
imaging. Cells were imaged directly in the plate wells
using an inverted fluorescent microscope (Nikon TE300).
Digital images of each sample at 400× magnification were
taken and recorded using OneSpot software.
Quantitative Caspase Activity
Caspase activity was quantitatively analyzed with a fluor-
ometric assay using the FLICA-based probes (Immuno-
chemistry Technologies, LLC) as described by the
manufacturer. Activity levels for caspases 2, 3/7, 8, and 9
were quantified with FLICA probes in addition to the total
caspase activity indicated from the pan-caspase FLICA
probe. Probes included FAM-VDVAD-fmk (caspase-2),
FAM-DEVD-fmk (caspase-3/7), FAM-LETD-fmk (caspase-
8), FAM-LEHD-fmk (caspase-9) and SR-VAD-fmk (pan-
caspase). A fluorometric plate reader was used to measure
the relative fluorescent units (RFUs) per sample at 1, 5, 9,
and 13 hours post infection.
At each time point (0, 4, 8, and 12 h) prior to labeling,
cells were mock-infected or infected with MNV-1 at MOI
= 3. Cells were harvested by scraping into 1.5 mL tubes 12
hours after the first inoculation. Cells were collected viaVirology Journal 2009, 6:139 http://www.virologyj.com/content/6/1/139
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centrifugation at 4,000 rpm for 10 minutes (2600 ×g). The
supernatant was discarded and 300 μL of the appropriate
1× FLICA probe in DMEM was added to the cell pellet.
Pellets were re-suspended by vortexing and incubated at
37°C for 1 hour with two brief vortexes to ensure ade-
quate mixing for labeling. Samples were washed with 1.0
mL of a 1× wash buffer diluted in PBS and centrifuged at
4,000 rpm for 5 minutes (2600 ×g); the supernatant was
aspirated and the wash was repeated. The pellets were re-
suspended in 400 μL of PBS. Each sample was thoroughly
mixed and 100 μL-aliquots were plated in triplicate in a
96-well plate. Fluorescence was measured with a fluoro-
metric plate reader. Pan-caspase samples were measured
with the 535/590 nm filter set, while all other samples
were measured with the 490/535 nm filter set. Relative
fluorescent units (RFUs) were recorded for each sample
and normalized as a percentage of controls.
Caspase-Independent Cell Death
Cell viability was monitored in infected cells in the pres-
ence and absence of the pan-caspase inhibitor and com-
pared to their non-infected counterparts. Cells were
seeded in 1.0 mL DMEM at a density of 5 × 105 cells per
well in four 12-well plates and incubated at 37°C over-
night. DMEM was replaced with 0.5 mL fresh medium
plus 2.5 μL DMSO (control), DMEM with 100 μM Boc-
D(OMe)-fmk (inhibitor control), DMEM with 2.5 μL
DMSO and virus, DMEM with 100 μM Boc-D(OMe)-fmk
and virus (inhibitor + virus). Each condition was repeated
in triplicate for all four time points. At 0, 12, 18, and 24
h.p.i. non-contrast cell images were taken and percent via-
bility was determined. Cells were imaged using an
inverted Nikon TE300 microscope at 200× and 400× mag-
nifications. Cells were then scraped, collected, and diluted
1:1 with Trypan Blue. 10 μL of the stained cells were
counted with a hemacytometer to determine the total cell
counts and percent viability.
Cell Staining
Cells infected in the presence and absence of the pan-cas-
pase inhibitor, Boc-D(OMe)-fmk, were stained with pro-
pidium iodide (PI) and Hoechst stain to measure
apoptosis as described by Pelfry et al. Briefly, cells were
seeded at a density of 5 × 105 cells per well in 1.0 mL
DMEM in 12-well plates and incubated overnight at
37°C. Media was replaced with 0.5 mL DMEM plus virus
(MOI of 3) for infected cells and 100 μM Boc-D(OMe)-
fmk for caspase-inhibited cells. Infected were harvested at
6, 12, 18, and 24 h.p.i. for PI and Hoechst staining.
Cells were scraped, collected into 1.5 mL tubes, and cen-
trifuged at 4000 rpm (2600 ×g) to pellet. The supernatant
was aspirated and replaced with 250 μL of 1.6 μg/mL
Hoechst stain diluted in sterile PBS. Cells were gently
mixed with a 1000 μL-volume pipette tip and then incu-
bated at 37°C for 15 minutes. 5 μL of 250 μg/mL PI was
added to the cells and allowed to briefly incubate before
centrifugation at 4000 rpm for 5 minutes (2600 ×g). The
supernatant was discarded, and the cells were gently re-
suspended in 20 μL of sterile PBS. 10 μL of cell suspension
were plated onto a glass slide with a cover slip in prepara-
tion for imaging.
Cells were imaged on a Nikon TE300 inverted micro-
scope. Digital cell images were taken at 400× magnifica-
tion with each filter set and the images were merged using
OneSpot software. Images were analyzed using ImageJ
and a cell counter plug-in. Each image was individually
analyzed for total cell counts and intensely stained cells.
Hoechst-stained cells were counted and differentiated as
having diffusely stained or intensely stained nuclei for
each image. PI-stained cells were counted for the total
number of membrane permeable cells per image. The per-
centage of cells with condensed chromatin was normal-
ized to the control percentages for each time point to
determine the virally induced changes in chromatin con-
densation.
Affinity purification and protein identification
Cells were grown in 175 cm2 flask until confluent and
infected as previously mentioned. At 12 hpi, mock-
infected and infected cells were harvested, pelleted, and
re-suspended in 1.0 mL with 10 μM biotin-X-DEVD-FMK
(Calbiochem Inc.) in cDMEM. One non-infected cell pel-
let was re-suspended in PBS alone to serve as a control.
Cells were allowed to incubate at 37°C for one hour, pel-
leted, and washed once in 1× wash buffer. Cells were
homogenized in 200 μL PBS binding buffer (0.15 M
NaCl, and 0.1% SDS). 15 μL streptavidin agarose resin
was then added to the cell lysate and mixed at room tem-
perature for three hours. The resin was washed with 1.0
mL of binding buffer four times. Resin was washed once
in PBS and digested with trypsin in PBS overnight at
37°C. Digested samples were analyzed with ESI-MS/MS,
and protein identification was performed with MASCOT
(Matrix Science) and Phenyx (GeneBio).
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